Skip to content
Research Article Open access CC BY 4.0

Exploration of Antioxidant, Antibacterial, and Alpha-glucosidase Inhibition Potential of Cirsium verutum (D. Don) Spreng Extracts: In vitro and in silico Approach

Manila Poudel, Nirmal Parajuli, Sabin Khanal, Bindira Gosain, Kanchan Shakhakarmi, Samjhana Bharati, Binita Maharjan, Timila Shrestha, Jhashanath Adhikari Subin, Ram Lal Swagat Shrestha, Bishnu Prasad Marasini

Asian Journal of Applied Chemistry Research · pp. 55–70 · Published 20 Jul 2024

10.9734/ajacr/2024/v15i4296

Abstract

Certain medicinal plants have been used to address common infectious as well as non-infectious diseases. Diabetes mellitus poses a major global health challenge, leading to significant mortality and morbidity each year. Finding side-effect-free treatments for diabetes has always been difficult. Bacterial resistance is recognized as a significant medical concern, highlighting the need to identify new compounds that could serve as potential starting points for addressing or managing infectious diseases. The study focused on the phytochemical extraction of Cirsium verutum (D. Don) Spreng, evaluating its bioactivity and identifying potential molecules through molecular docking that could act as starting compounds for creating alternative drugs to address specific health issues. The aqueous extract demonstrated superior performance, displaying the highest phenolic content and exhibiting notable inhibitory effects on the alpha-glucosidase enzyme (31.39±0.02 mg GAE/gm and 70.46% inhibition with an IC50 value of 37.37±1.46 µg/mL, respectively). The free radical scavenging activity using DPPH indicated the maximum activity in the hexane extracts an IC50 of 442.17±0.42 µg/mL. The extracts of C. verutum demonstrated minimum inhibitory concentration (MIC) values ranging from 0.78 to 12.5 mg/mL and minimum bactericidal concentration (MBC) values ranging from 3.12 to 25 mg/mL in the antibacterial assay. The fully characterized compounds from C. verutum were searched from various papers, followed by their molecular docking. In the molecular docking study, it was discovered that among the seven top candidates, pectolinarin (01) was identified as the most promising candidate, exhibiting a docking score of -11.076 kcal/mol against intestinal alpha-glucosidase. This integrated study approach will aid in the discovery of new antibiotics and the management of diabetes.

Bioactivity antibacterial alpha-glucosidase antioxidant molecular docking diabetes management

References (33)

  1. 1 Estimation of total phenolic content and other oxidation substrates in plant tissues using Folin–Ciocalteu reagent [DOI]
  2. 2 End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design [DOI]
  3. 3 Using PyMOL as a platform for computational drug design [DOI]
  4. 4 The role and place of medicinal plants in the strategies for disease prevention [DOI]
  5. 5 Indigenous Use and Ethnopharmacology of Medicinal Plants in Far-West Nepal [DOI]
  6. 6 Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro [DOI]
  7. 7 Management of diabetes and hyperglycaemia in the hospital [DOI]
  8. 8 Recent advances in natural products from plants for treatment of liver diseases [DOI]
  9. 9 Advances in the Management of Diabetes Mellitus: A Focus on Personalized Medicine [DOI]
  10. 10 Highly Flexible Ligand Docking: Benchmarking of the DockThor Program on the LEADS-PEP Protein–Peptide Data Set [DOI]
  11. 11 Effects of flavonoids on α-glucosidase activity: Potential targets for glucose homeostasis [DOI]
  12. 12 Evaluation of Antioxidant, Antidiabetic and Antiobesity Potential of Selected Traditional Medicinal Plants [DOI]
  13. 13 A pharmacological appraisal of medicinal plants with antidiabetic potential [DOI]
  14. 14 Diabetes and plant‐derived natural products: From ethnopharmacological approaches to their potential for modern drug discovery and development [DOI]
  15. 15 Determination of Free Radical Scavenging Activity of Plant Extracts Through DPPH Assay: An EPR and UV–Vis Study [DOI]
  16. 16 Evaluation of Nutritional, Phytochemical, and Mineral Composition of Selected Medicinal Plants for Therapeutic Uses from Cold Desert of Western Himalaya [DOI]
  17. 17 Antioxidative Activity and Inhibition of Key Enzymes Linked to Type-2 Diabetes (α-Glucosidase and α-Amylase) by Khaya Senegalensis [DOI]
  18. 18 Molecular Docking studies on the Anti-fungal activity of Allium sativum (Garlic) against Mucormycosis (black fungus) by BIOVIA discovery studio visualizer 21.1.0.0 [DOI]
  19. 19 Traditional Uses, Phytochemical Composition, Pharmacological Properties, and the Biodiscovery Potential of the Genus Cirsium [DOI]
  20. 20 α-Glucosidase inhibitory activities of flavonoid derivatives isolated from Bouea macrophylla : in vitro and in silico studies [DOI]
  21. 21 Current status of Indian medicinal plants with antidiabetic potential: a review [DOI]
  22. 22 Xanthones inhibitors of α-glucosidase and glycation from Garcinia nobilis [DOI]
  23. 23 First evidence of the analgesic activity of govaniadine, an alkaloid isolated fromCorydalis govanianaWall. [DOI]
  24. 24 Alternative to Antibiotics from Herbal Origin - Outline of a Comprehensive Research Project [DOI]
  25. 25 Polysaccharides from Dolichos biflorus Linn and Trachyspermum ammi Linn seeds: isolation, characterization and remarkable antimicrobial activity [DOI]
  26. 26 Synthesis, molecular docking, α-glucosidase inhibition, and antioxidant activity studies of novel benzimidazole derivatives [DOI]
  27. 27 Assessment of iridoids and their similar structures as antineoplastic drugs by in silico approach [DOI]
  28. 28 Flavonoid composition and antimicrobial activity of Cirsium rivulare (Jacq.) All. flowers [DOI]
  29. 29 Antidiabetic and antioxidant activities: Is there any link between them? [DOI]
  30. 30 Geometrical and thermodynamic stability of govaniadine scaffold adducts with dopamine receptor D1 [DOI]
  31. 31 Cirsium verutum (D. Don) Spreng. Asteraceae [DOI]
  32. 32 The design of TOPK inhibitors using structure-based pharmacophore modeling and molecular docking based on an MD-refined homology model [DOI]
  33. 33 Cirsium verutum (D. Don) Spreng. Asteraceae [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

46

Page views

0

PDF downloads

12

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.